The psychoactive properties of Cannabis sativa and its major biologically active constituent, A9-tetrahydrocannabinol, have been known for years. The recent identification and cloning of a specific cannabinoid receptor suggest that cannabinoids mimic endogenous compounds affecting neural signals for mood, memory, movement, and pain. Using whole-cell voltage clamp and the cannabinomimetic aminoalkylindole WIN 55,212-2, we have found that cannabinoid receptor activation reduces the amplitude of voltagegated calcium currents in the neuroblastoma-glioma cell line NG108-15. The inhibition is potent, being half-maximal at less than 10 nM, and reversible. The inactive enantiomer, WIN 55,212-3, does not reduce calcium currents even at 1 FzM. Of the several types of calcium currents in NG108-15 cells, cannabinoids predominantly inhibit an a-conotoxin-sensitive, high-voltage-activated calcium current. Inhibition was blocked by incubation with pertussis toxin but was not altered by prior treatment with hydrolysis-resistant cAMP analogues together with a phosphodiesterase inhibitor, suggesting that the transduction pathway between the cannabinoid receptor and calcium channel involves a pertussis toxin-sensitive GTP-binding protein and is independent of cAMP metabolism. However, the development of inhibition is considerably slower than a pharmacologically similar pathway used by an a2-adrenergic receptor in these cells. Our results suggest that inhibition of N-type calcium channels, which could decrease excitability and neurotransmitter release, may underlie some of the psychoactive effects of cannabinoids.
The principal cannabinoid and major psychoactive ingredient in extracts of the marijuana plant (Cannabis sativa) is A9-tetrahydrocannabinol (1) . Because of its widespread recreational use and potential therapeutic applications (1, 2) , a search for its cellular site(s) of action has been the focus of considerable attention. However, despite much work, the mechanism(s) of action remain uncertain (3) . The only wellestablished biochemical effect is an inhibition of hormonestimulated adenylyl cyclase via a pertussis toxin (PTX)-sensitive GTP-binding regulatory protein (4, 5) . As many receptors that couple to adenylyl cyclase via the G protein G, also interact with ion channels (6), we investigated the relationship between cannabinoid receptor activation and calcium current amplitude (Ica) in neuroblastoma-glioma (NG108-15) cells. The low aqueous solubility of the naturally occurring cannabinoids and their propensity to stick to glass and plastic makes experiments with them difficult and prone to artifacts (7) . In our studies we have taken advantage of the recent development of the nonclassical cannabinoids (8) and the aminoalkylindoles (9) , two families of cannabinomimetic compounds that we will refer to loosely as ' cannabinoids." These compounds appear to mimic the receptor-mediated effects of the naturally occurring cannabinoids in every way tested to date (8) (9) (10) (11) (12) (13) . Their increased potency and aqueous solubility circumvent many of the problems associated with the study of naturally occurring cannabinoids.
METHODS
Materials. Minimum essential medium and fetal bovine serum were from GIBCO or Sigma. Prostaglandin E1, 3-isobutyl-1-methylxanthine, Nystatin, dibutyryl-cAMP, norepinephrine, albumin, and hypoxanthine/aminopterin/ thymidine were from Sigma. PTX was from List. 8-Chlorophenylthio-cAMP was from Boehringer Mannheim. Tetrodotoxin was from Calbiochem. Pluronic F127 was from Molecular Probes. w-Conotoxin GVIA (wCTX) was from Peninsula Laboratories.
Cell Culture. NG108-15 cells (passages [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] were grown by standard techniques on polylysine-coated coverslip fragments (14, 15) . Four to seven days prior to recording, differentiation was induced by decreasing the serum content of the medium to 1% and by adding 100 ,uM IBMX and 10 ,uM prostaglandin E1. In the PTX experiments, differentiated NG108-15 cells were cultured for an additional 20-28 hr in medium containing PTX at 500 ng/ml. Control cells were treated similarly, except PTX heated at 95°C for 15 min was substituted for native PTX. As a control for variability in calcium channel expression and cannabinoid response, concurrent controls from the same passage were always used.
Current Recording. To minimize alterations in the cytoplasm, we recorded currents by using the Pluronic modification (16) of the Nystatin perforated-patch technique (17) of whole-cell GfQ-seal clamp (18) . Pipettes were pulled from hematocrit microcapillary glass (VWR). The tip contained 100 mM CsCl/10 mM CsEGTA/5 mM MgCl2/40 mM Hepes, pH 7.30, with CsOH. The rest of the pipette was backfilled with the same solution to which was added Pluronic F127 (5 ,g/ml) and Nystatin (5 rected. Where appropriate, data are expressed as mean ± SE.
Drug Application. Cannabinoid stocks were dissolved at 10 mM in dimethyl sulfoxide and diluted into the perfusion solution. The maximum final concentration of dimethyl sulfoxide, 0.1% with 10 AtM cannabinoid, had no consistent effect on ICa. In most experiments, drug-containing solution was applied with a system of reservoirs connected by multiple inlet valves. However, in one set of experiments we were concerned that the slow onset of action of the synthetic cannabinoids might be secondary to their adsorption to the tubing of the perfusion system, resulting in a ramp, rather than a step, application of agonist to the cell. We sought to A 14 mV Proc. NatI. Acad. Sci. USA 89 (1992) circumvent this problem by constructing a U-tube apparatus using a rapid perfusion system (19) . Drug-containing solution flowed constantly from one side of a theta tubing, while the other side, draining by gravity, immediately aspirated the drug back again. The cell was positioned 250 tim from the tubing. (By suitable selection of the reservoir and drain heights, no drug action could be detected until the tip of the theta tubing was less than 100 ,um from the cell.) Then a computer-controlled valve on the drain tubing was suddenly closed, causing the drug-containing solution to flow out over the cell. As determined visually with phenol red and quantitatively by changes in holding current, during application of 25 mM KCI-containing Ringer's, solution change was com- (Fig. 1A) . Bath application of the aminoalkylindole WIN 55,212-2 (WIN) inhibited a portion of this curreflt. The inhibition was concentration-dependent with a threshold below 1 nM and a maximal reduction of 43 ± 5% (n = 7, mean + SE) Of ICa at 100 nM (Fig. 1B) . The inhibition was stereospecific, as 1 jLM of the WIN 55,212-2 enantiomer, WIN 55,212-3, did not inhibit ICa (0 ± 1%, n = 5). Inhibition by WIN was reversed by removing the drug (Fig. 1C) . Differentiated NG108-15 cells generally contain both high-and low-voltage-activated calcium currents whose activation is first seen at -40 and 0 mV, respectively (Fig.  1D) . Only the high-voltage-activated component was inhibited by WIN. The nonclassical cannabinoid CP 55,940 (100 nM) also reduced ICa (Fig. 1E ) (36 + 7%, n = 7); however, in contrast to the aminoalkylindole, complete reversal was not seen upon washout of CP 55,940. The actions of the two drugs occlude each other, and no further inhibition OfICa was seen by WIN after ICa had been maximally suppressed by CP 55,940 and vice versa (n = 3).
The cloned cannabinoid receptor has an amino acid sequence typical of G-protein-coupled receptors (20) . Like the known inhibition of adenylyl cyclase (4, 5), the cannabinoidmediated inhibition of ICa could be blocked by treating the cells with PTX (Fig. 2) . Nevertheless, the inhibition of ICa appears to be independent of adenylyl cyclase activity and reductions in cAMP, as it persisted when hydrolysis-resistant cAMP analogues were combined with inhibitors of phosphodiesterases to keep cellular levels of cAMP high. Thus, in cells preincubated for 5 min with 1 mM dibutyryl-cAMP and 100 ,tM IBMX, 100 nM WIN reduced ICa by 36 ± 3% (n = 5), whereas in parallel control cells, 100 nM WIN reduced ICa by 31 ± 4% (n = 4). Similarly, 100 ,tM 8-chlorophenylthiocAMP and 100 pLM IBMX did not prevent cannabinoid inhibition of ICa (n = 6). Furthermore, these treatments with cAMP analogs did not increase Ica.
Norepinephrine also inhibits Ica via a PTX-sensitive process that is known to be independent of cAMP metabolism in NG108-15 cells (21 nephrine developed with a time constant of <2.0 s (n = 6, Fig.  3B ). On the other hand, inhibition by WIN was consistently slower, with time constants of 8.9 s (n = 7) and 8.2 s (n = 6) for 1 and 10,uM WIN, respectively (Fig. 3B) . This experiment used a method of rapid agonist application that reduced the possibility that delivery was slowed by adsorption of compounds to the perfusion tubing. A similarly slow onset of inhibition was seen with 10 ,uM CP 55,940 (n = 3).
At least two components of high-voltage-activated ICa, with L-channel and N-channel properties, can be distinguished in NG108-15 cells. Which subtype ofcalcium channel is being inhibited by cannabinoids? An L-type channel is present, since the dihydropyridine antagonist nitrendipine (1 ,M) reduced Ick by 27 ± 6% (n = 8), and the dihydropyridine agonist S (+)-202,791 (1 uM) increased ICa by 55 ± 8% (n = 11). However, L-type channels seem insensitive to cannabinoid action, as pretreatment with either dihydropyridine did not alter the portion of ICa inhibited by 100 nM WIN (normalized to Ica prior to pretreatment; Fig. 4A ). In contrast, pretreatment with 1 ,uM wCTX, which blocks N-type channels, decreased ICa by 38 ± 12% (n = 10), and in these cells, inhibition by 100 nM WIN was almost abolished (Fig.   4A ). Furthermore, 100 nM WIN did not inhibit the current remaining after addition of wCTX mixed with S (+)-202,791, conditions that emphasize L-type ICa (Fig. 4) . Thus the majority of ICa inhibited by cannabinoids appears to be carried via N-type calcium channels. (1,uM) inhibits ICa during depolarizing steps to +14 mV. Addition of the dihydropyridine agonist S (+)-202,791 (1,uM) increases ICa Subsequent addition of 100 nM WIN has no effect on ICa. The record has not been leak-subtracted and is representative of four experiments.
NG108-15 cells potently and reversibly. As the inhibited current is mostly sensitive to wCTX (Fig. 4) , we classify it as being through N-type calcium channels. How might our findings relate to cannabinoid pharmacology and to the functional role of the as yet undiscovered endogenous cannabinoid? Our results suggest that cannabinoids will blunt processes dependent on calcium entry through N-type channels. As calcium is a versatile second messenger in neurons, many processes will be affected (22, 23) . One consequence that could explain some of the psychoactive effects of the cannabinoids is reduction of the release of neurotransmittercontaining small clear vesicles (24, 25) -presynaptic inhibition. Indeed, the cannabinoid receptor is largely located on presynaptic structures (26) (27) (28) and cannabinoids inhibit electrically stimulated acetylcholine release in both the ileum (29, 30) and the vas deferens (9) .
The signaling pathway between the cannabinoid receptor and N-type calcium channels is PTX-sensitive (Fig. 2) We have found a specific inhibition of N-type calcium channels, but further investigation will most likely find cannabinoid receptor-mediated actions with other ion channels, as there is ample evidence that several channel types interact either directly or indirectly with G proteins. In particular, activation of an inwardly rectifying potassium channel is another common direct action of PTX-sensitive G proteins (6) . The finding of electrophysiological mechanisms of cannabinoid action makes all the more pressing the need to discover the endogenous ligand for this interesting neurotransmitter pathway.
